HOSPITAL COSTS OF ADVERSE EVENTS IN PATIENTS RECEIVING TREATMENT FOR METASTATIC COLORECTAL CANCER

被引：0
|
作者：
Fu, A. Z. [1 ]
Zhao, Z. [2 ]
Wang, S. [2 ]
Gao, S. [2 ]
Barber, B. [2 ]
Liu, G. [3 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
[3] Peking Univ, Beijing 100871, Peoples R China
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 03期
关键词：
D O I：
10.1016/j.jval.2011.02.958
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A173 / A173
页数：1
相关论文
共 50 条
  • [1] COSTS OF HOSPITAL EVENTS IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Overbeek, J. A.
    Zhao, Z.
    van Herk-Sukel, M. P. P.
    Barber, B. L.
    Gao, S.
    Herings, R. M. C.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A162 - A162
  • [2] Costs of Hospital Events in Patients with Metastatic Colorectal Cancer
    Overbeek, Jetty A.
    Zhao, Zhongyun
    van Herk-Sukel, Myrthe P. P.
    Barber, Beth L.
    Gao, Sue
    Herings, Ron M. C.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S277 - S277
  • [3] HOSPITAL COSTS OF ADVERSE EVENTS IN PATIENTS WITH METASTATIC MELANOMA
    Ma, Q.
    Zhao, Z.
    Barber, B. L.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A82 - A82
  • [4] The Importance of Keeping Patients With Metastatic Colorectal Cancer on Treatment Through the Management of Adverse Events
    Grothey, Axel
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (10) : 15 - 19
  • [5] Association of Age With Treatment-Related Adverse Events and Survival in Patients With Metastatic Colorectal Cancer
    Meng, Lingbin
    Thapa, Ram
    Delgado, Maria G.
    Gomez, Maria F.
    Ji, Rui
    Knepper, Todd C.
    Hubbard, Joleen M.
    Wang, Xuefeng
    Permuth, Jennifer B.
    Kim, Richard D.
    Laber, Damian A.
    Xie, Hao
    [J]. JAMA NETWORK OPEN, 2023, 6 (06) : E2320035
  • [6] Health care costs for prostate cancer patients receiving androgen deprivation therapy: treatment and adverse events
    Krahn, M. D.
    Bremner, K. E.
    Luo, J.
    Alibhai, S. M. H.
    [J]. CURRENT ONCOLOGY, 2014, 21 (03) : E457 - E465
  • [7] Bevacizumab in the treatment of metastatic colorectal cancer: Safety profile and management of adverse events
    Hurwitz, Herbert
    Saini, Shermini
    [J]. SEMINARS IN ONCOLOGY, 2006, 33 (05) : S26 - S34
  • [8] Risk of antiangiogenic adverse events in metastatic colorectal cancer patients receiving aflibercept in combination with chemotherapy: A meta-analysis
    Ge, Pu
    Han, Chunyan
    Reyila, Abudurousuli
    Liu, Diyue
    Hong, Wenying
    Liu, Jiaxin
    Zhang, Jinzi
    Han, Xiao
    Li, Xialei
    Huang, Mengjie
    Fan, Siyuan
    Kaierdebieke, Ayidana
    Wu, Xiaoyu
    Huang, Xiaolu
    Guo, Weirui
    Liu, Siyu
    Bian, Ying
    [J]. MEDICINE, 2023, 102 (35) : E34793
  • [9] Adverse Events Associated With Bevacizumab and Chemotherapy in Older Patients With Metastatic Colorectal Cancer
    Shankaran, Veena
    Mummy, David
    Koepl, Lisel
    Blough, David
    Yim, Yeun Mi
    Yu, Elaine
    Ramsey, Scott
    [J]. CLINICAL COLORECTAL CANCER, 2013, 12 (03) : 204 - +
  • [10] Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer
    Fakih, M.
    Vincent, M.
    [J]. CURRENT ONCOLOGY, 2010, 17 : S18 - S30
12345